Your browser doesn't support javascript.
loading
Dynamic changes of the proportion of HLA-DR and CD38 coexpression subsets on T lymphocytes during IFN-based chronic hepatitis B treatment.
Lin, Yanjie; Shen, Ge; Xie, Si; Bi, Xiaoyue; Lu, Huihui; Yang, Liu; Jiang, Tingting; Deng, Wen; Wang, Shiyu; Zhang, Lu; Lu, Yao; Gao, Yuanjiao; Hao, Hongxiao; Wu, Shuling; Liu, Ruyu; Chang, Min; Xu, Mengjiao; Hu, Leiping; Chen, Xiaoxue; Huang, Ronghai; Li, Minghui; Xie, Yao.
Afiliação
  • Lin Y; Department of Hepatology Division 2, Peking University Ditan Teaching Hospital, Beijing, China.
  • Shen G; Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Xie S; Division of Hepatology, Hepato-Pancreato-Biliary Center, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.
  • Bi X; Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Lu H; Department of Obstetrics and Gynecology, Wuhan Children's Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Yang L; Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Jiang T; Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Deng W; Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Wang S; Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Zhang L; Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Lu Y; Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Gao Y; Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Hao H; Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Wu S; Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Liu R; Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Chang M; Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Xu M; Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Hu L; Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Chen X; Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Huang R; Department of General Surgery, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Li M; Department of Hepatology Division 2, Peking University Ditan Teaching Hospital, Beijing, China.
  • Xie Y; Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Front Immunol ; 13: 1116160, 2022.
Article em En | MEDLINE | ID: mdl-36761161
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 2_ODS3 Problema de saúde: 2_enfermedades_transmissibles Assunto principal: Hepatite B Crônica / Antígenos de Superfície da Hepatite B Tipo de estudo: Observational_studies Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 2_ODS3 Problema de saúde: 2_enfermedades_transmissibles Assunto principal: Hepatite B Crônica / Antígenos de Superfície da Hepatite B Tipo de estudo: Observational_studies Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China